PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 133 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $62,066,000 | +7.8% | 1,921,554 | +14.2% | 0.01% | -8.3% |
| Q3 2016 | $57,571,000 | +7.2% | 1,682,381 | +5.7% | 0.01% | 0.0% |
| Q2 2016 | $53,688,000 | -36.0% | 1,591,688 | +0.6% | 0.01% | -36.8% |
| Q1 2016 | $83,827,000 | -30.2% | 1,582,234 | +1.2% | 0.02% | -32.1% |
| Q4 2015 | $120,108,000 | +76.2% | 1,564,114 | -5.7% | 0.03% | +55.6% |
| Q3 2015 | $68,185,000 | -40.8% | 1,658,993 | +1.8% | 0.02% | -35.7% |
| Q2 2015 | $115,216,000 | -19.4% | 1,629,188 | +1.3% | 0.03% | -17.6% |
| Q1 2015 | $142,946,000 | +5.7% | 1,608,851 | +5.5% | 0.03% | +3.0% |
| Q4 2014 | $135,242,000 | +1.2% | 1,525,402 | +10.6% | 0.03% | -13.2% |
| Q3 2014 | $133,699,000 | +7.5% | 1,379,476 | +1.8% | 0.04% | +8.6% |
| Q2 2014 | $124,427,000 | +43.8% | 1,354,524 | +9.5% | 0.04% | +34.6% |
| Q1 2014 | $86,552,000 | +24.8% | 1,236,636 | +2.5% | 0.03% | +23.8% |
| Q4 2013 | $69,359,000 | +19.9% | 1,206,457 | +0.3% | 0.02% | +5.0% |
| Q3 2013 | $57,845,000 | +88.0% | 1,203,222 | +13.4% | 0.02% | +81.8% |
| Q2 2013 | $30,775,000 | – | 1,061,198 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |